NCT00495170 Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00495040 Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00492843 Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis Status TERMINATED Phase PHASE4
NCT00491335 HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers Status COMPLETED Phase N/A
NCT00483639 Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer Status COMPLETED Phase N/A
NCT00475098 Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) Status COMPLETED Phase PHASE3
NCT00471978 DNA Analysis of Blood and Tissue from Patients with Lung Cancer Status RECRUITING Phase N/A
NCT00471835 Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT00471432 OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors Status COMPLETED Phase PHASE1
NCT00469976 Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT00469898 Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00466232 Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00465907 Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer Status TERMINATED Phase PHASE2
NCT00465725 A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00460668 The Effect of Post-thoracotomy Pulmonary Rehabilitation on Quality of Life Status COMPLETED Phase NA
NCT00459121 Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery Status TERMINATED Phase PHASE2